Centiva Capital LP Makes New $650,000 Investment in Veralto Co. (NYSE:VLTO)

Centiva Capital LP purchased a new stake in shares of Veralto Co. (NYSE:VLTO - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 6,385 shares of the company's stock, valued at approximately $650,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Park Avenue Securities LLC increased its stake in shares of Veralto by 18.4% in the 4th quarter. Park Avenue Securities LLC now owns 17,228 shares of the company's stock valued at $1,755,000 after acquiring an additional 2,676 shares during the last quarter. Czech National Bank raised its holdings in shares of Veralto by 6.5% in the fourth quarter. Czech National Bank now owns 53,622 shares of the company's stock valued at $5,461,000 after purchasing an additional 3,284 shares during the last quarter. Assenagon Asset Management S.A. grew its holdings in shares of Veralto by 15.5% in the 4th quarter. Assenagon Asset Management S.A. now owns 14,115 shares of the company's stock valued at $1,438,000 after acquiring an additional 1,889 shares in the last quarter. David Wealth Management LLC acquired a new position in shares of Veralto during the 4th quarter worth approximately $1,013,000. Finally, Border to Coast Pensions Partnership Ltd raised its position in Veralto by 497.8% during the fourth quarter. Border to Coast Pensions Partnership Ltd now owns 314,180 shares of the company's stock worth $31,978,000 after acquiring an additional 261,623 shares in the last quarter. 91.28% of the stock is owned by institutional investors.

Analyst Ratings Changes

VLTO has been the subject of several research reports. Stifel Nicolaus raised their price objective on shares of Veralto from $102.00 to $104.00 and gave the stock a "buy" rating in a research report on Thursday, May 1st. Citigroup lowered their price objective on shares of Veralto from $116.00 to $100.00 and set a "neutral" rating for the company in a research report on Monday, April 14th. Northcoast Research began coverage on shares of Veralto in a report on Tuesday, May 6th. They issued a "buy" rating and a $110.00 target price for the company. Royal Bank of Canada boosted their price objective on Veralto from $103.00 to $104.00 and gave the stock a "sector perform" rating in a research report on Thursday, May 1st. Finally, Robert W. Baird raised their price target on shares of Veralto from $105.00 to $106.00 and gave the company a "neutral" rating in a research note on Thursday, May 1st. Six research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat.com, Veralto presently has a consensus rating of "Hold" and a consensus target price of $110.09.

Insider Buying and Selling

In other news, CEO Jennifer Honeycutt sold 10,414 shares of the firm's stock in a transaction dated Tuesday, February 25th. The stock was sold at an average price of $100.35, for a total value of $1,045,044.90. Following the completion of the transaction, the chief executive officer now directly owns 104,496 shares in the company, valued at $10,486,173.60. This trade represents a 9.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Melissa Aquino sold 463 shares of the company's stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $99.60, for a total value of $46,114.80. Following the completion of the sale, the senior vice president now owns 20,761 shares in the company, valued at approximately $2,067,795.60. This represents a 2.18% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 64,578 shares of company stock valued at $6,192,048 over the last quarter. 0.36% of the stock is owned by corporate insiders.

Veralto Trading Up 3.4%

Shares of NYSE:VLTO traded up $3.27 during trading on Monday, reaching $100.33. 1,329,690 shares of the company traded hands, compared to its average volume of 1,484,985. Veralto Co. has a 52-week low of $83.87 and a 52-week high of $115.00. The company has a current ratio of 1.92, a quick ratio of 1.69 and a debt-to-equity ratio of 1.27. The business's fifty day moving average is $94.22 and its 200-day moving average is $99.74. The firm has a market capitalization of $24.87 billion, a price-to-earnings ratio of 30.04, a P/E/G ratio of 4.24 and a beta of 0.99.

Veralto (NYSE:VLTO - Get Free Report) last released its earnings results on Tuesday, April 29th. The company reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.08. Veralto had a return on equity of 49.29% and a net margin of 16.04%. The company had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.28 billion. During the same period in the previous year, the business earned $0.84 earnings per share. Veralto's quarterly revenue was up 6.9% compared to the same quarter last year. As a group, analysts forecast that Veralto Co. will post 3.66 EPS for the current year.

Veralto Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 30th. Investors of record on Monday, March 31st were issued a dividend of $0.11 per share. This represents a $0.44 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date of this dividend was Monday, March 31st. Veralto's payout ratio is currently 12.57%.

Veralto Profile

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.